WO2008120744A1 - ５員環アミド化合物およびその用途 - Google Patents

５員環アミド化合物およびその用途 Download PDF

Info

Publication number
WO2008120744A1
WO2008120744A1 PCT/JP2008/056173 JP2008056173W WO2008120744A1 WO 2008120744 A1 WO2008120744 A1 WO 2008120744A1 JP 2008056173 W JP2008056173 W JP 2008056173W WO 2008120744 A1 WO2008120744 A1 WO 2008120744A1
Authority
WO
WIPO (PCT)
Prior art keywords
amide compound
membered cyclic
cyclic amide
compound
disclosed
Prior art date
Application number
PCT/JP2008/056173
Other languages
English (en)
French (fr)
Inventor
Tetsuya Iida
Minoru Ubukata
Ikuo Mitani
Yuichi Nakagawa
Masahiro Tanaka
Original Assignee
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc. filed Critical Japan Tobacco Inc.
Publication of WO2008120744A1 publication Critical patent/WO2008120744A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

　優れたＳＣＤ１活性阻害作用を有する化合物を提供すること。下記一般式［Ａ－１’］で表される化合物又はその医薬上許容される塩、或いはその溶媒和物： ［式中、各記号は明細書中で定義した通りである。］。
PCT/JP2008/056173 2007-03-30 2008-03-28 ５員環アミド化合物およびその用途 WO2008120744A1 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007095470 2007-03-30
JP2007-095470 2007-03-30
US92580307P 2007-04-23 2007-04-23
US60/925,803 2007-04-23

Publications (1)

Publication Number Publication Date
WO2008120744A1 true WO2008120744A1 (ja) 2008-10-09

Family

ID=39808324

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/056173 WO2008120744A1 (ja) 2007-03-30 2008-03-28 ５員環アミド化合物およびその用途

Country Status (1)

Country Link
WO (1) WO2008120744A1 (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009106203A1 (en) * 2008-02-25 2009-09-03 Merck Patent Gmbh Glucokinase activators
WO2013056148A2 (en) 2011-10-15 2013-04-18 Genentech, Inc. Methods of using scd1 antagonists
US10973810B2 (en) 2017-01-06 2021-04-13 Yumanity Therapeutics, Inc. Methods for the treatment of neurological disorders
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
US11970486B2 (en) 2017-10-24 2024-04-30 Janssen Pharmaceutica Nv Compounds and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0324066A (ja) * 1989-06-14 1991-02-01 Bayer Ag ２‐アシルアミノ‐４‐ハロゲノ‐５‐ニトロチアゾール誘導体、その製造方法、殺有害生物剤としてのその利用、および新規中間体
WO2007022258A1 (en) * 2005-08-17 2007-02-22 Schering Corporation Novel high affinity thiophene-based and furan-based kinase ligands
WO2008044767A1 (fr) * 2006-10-13 2008-04-17 Takeda Pharmaceutical Company Limited Dérivé d'amine aromatique et utilisation de celui-ci

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0324066A (ja) * 1989-06-14 1991-02-01 Bayer Ag ２‐アシルアミノ‐４‐ハロゲノ‐５‐ニトロチアゾール誘導体、その製造方法、殺有害生物剤としてのその利用、および新規中間体
WO2007022258A1 (en) * 2005-08-17 2007-02-22 Schering Corporation Novel high affinity thiophene-based and furan-based kinase ligands
WO2008044767A1 (fr) * 2006-10-13 2008-04-17 Takeda Pharmaceutical Company Limited Dérivé d'amine aromatique et utilisation de celui-ci

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009106203A1 (en) * 2008-02-25 2009-09-03 Merck Patent Gmbh Glucokinase activators
JP2014208665A (ja) * 2008-02-25 2014-11-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ グルコキナーゼ活性化剤
WO2013056148A2 (en) 2011-10-15 2013-04-18 Genentech, Inc. Methods of using scd1 antagonists
US9358250B2 (en) 2011-10-15 2016-06-07 Genentech, Inc. Methods of using SCD1 antagonists
US10973810B2 (en) 2017-01-06 2021-04-13 Yumanity Therapeutics, Inc. Methods for the treatment of neurological disorders
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
US11970486B2 (en) 2017-10-24 2024-04-30 Janssen Pharmaceutica Nv Compounds and uses thereof

Similar Documents

Publication Publication Date Title
WO2008120759A1 (ja) ウレア化合物およびその用途
WO2008123469A1 (ja) ６員環アミド化合物およびその用途
TW200732336A (en) Alyphactic heterocyclic compounds
WO2009048101A1 (ja) アミド化合物
WO2009051244A1 (ja) 複素環化合物
WO2007135527A3 (en) Benzimidazolyl compounds
MY146923A (en) Novel piperazine compound, and use thereof as hcv polymerase inhibitor
EP1864665A4 (en) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
WO2008011130A3 (en) Amide compounds
WO2009154300A3 (en) Heterocyclic compound and use thereof
WO2009060835A1 (ja) 新規ユビキリン結合性小分子
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
WO2008011131A3 (en) Amide compounds
WO2007136592A3 (en) 2-0x0-l,2-dihydr0quin0line derivatives, compositions, and uses thereof as antiproliferative agents
WO2006105888A3 (de) Synergistische fungizide wirkstoffkombinationen
WO2004101528A3 (en) Isoquinoline derivatives and their use as gfat inhibitors
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
WO2008153159A1 (ja) アミン化合物及びその医薬用途
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
WO2009028655A1 (ja) 複素環化合物およびその用途
WO2008105526A1 (ja) マクロ環状化合物
WO2007017728A3 (en) Novel heterocyclic compounds
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
WO2008114812A1 (ja) Jak阻害剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08739291

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08739291

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP